Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Kidney transplantation under FK 506.
|
JAMA
|
1990
|
7.45
|
2
|
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
|
Transplant Proc
|
1990
|
4.90
|
3
|
Kidney transplantation under FK 506 immunosuppression.
|
Transplant Proc
|
1991
|
3.31
|
4
|
Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway.
|
J Virol
|
2001
|
2.76
|
5
|
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506.
|
Lancet
|
1990
|
2.66
|
6
|
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression.
|
Transplantation
|
1994
|
2.50
|
7
|
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy.
|
Am J Transplant
|
2006
|
2.48
|
8
|
Characterization of influenza virus RNA complete transcripts.
|
Virology
|
1982
|
2.31
|
9
|
FK 506 in clinical kidney transplantation.
|
Transplant Proc
|
1991
|
2.29
|
10
|
A prospective randomized trial of FK506-based immunosuppression after renal transplantation.
|
Transplantation
|
1995
|
2.09
|
11
|
FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood.
|
Lancet
|
1990
|
1.94
|
12
|
Influenza virus RNA segment 7 has the coding capacity for two polypeptides.
|
Virology
|
1980
|
1.80
|
13
|
Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report.
|
Transplant Proc
|
1993
|
1.72
|
14
|
Nucleotide sequences at the terminal of La Crosse virus RNAs.
|
Nucleic Acids Res
|
1980
|
1.61
|
15
|
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients.
|
Transplant Proc
|
1991
|
1.56
|
16
|
Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway.
|
Virology
|
2005
|
1.56
|
17
|
Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents.
|
Proc Natl Acad Sci U S A
|
1999
|
1.54
|
18
|
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis.
|
Am J Transplant
|
2001
|
1.48
|
19
|
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
|
Transplantation
|
1992
|
1.45
|
20
|
Doubts using family history, age, alpha-fetoprotein and total human chorionic gonadotrophin in screening for Down's syndrome.
|
Br J Obstet Gynaecol
|
1994
|
1.43
|
21
|
Adverse effects associated with the use of FK 506.
|
Transplant Proc
|
1991
|
1.41
|
22
|
FK 506 conversion of renal allografts failing cyclosporine immunosuppression.
|
Transplant Proc
|
1991
|
1.37
|
23
|
BK virus infection in a kidney allograft diagnosed by needle biopsy.
|
Am J Kidney Dis
|
1995
|
1.28
|
24
|
A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.
|
Clin Transplant
|
1994
|
1.15
|
25
|
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.
|
Transplantation
|
1999
|
1.14
|
26
|
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.
|
Transplant Proc
|
1995
|
1.13
|
27
|
FK506 in pediatric kidney transplantation--primary and rescue experience.
|
Pediatr Nephrol
|
1995
|
1.11
|
28
|
Tacrolimus in renal transplantation.
|
Transplant Proc
|
1996
|
1.10
|
29
|
An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders.
|
J Clin Pharmacol
|
1993
|
1.09
|
30
|
The spectrum of ciclosporin nephrotoxicity.
|
Am J Nephrol
|
1990
|
1.05
|
31
|
FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.
|
Springer Semin Immunopathol
|
1993
|
1.02
|
32
|
Pediatric renal transplantation under tacrolimus-based immunosuppression.
|
Transplantation
|
1999
|
1.00
|
33
|
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.
|
Transplant Proc
|
1997
|
0.98
|
34
|
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up.
|
Am J Transplant
|
2008
|
0.98
|
35
|
Structure and synthesis of influenza virus complementary RNAs.
|
Philos Trans R Soc Lond B Biol Sci
|
1980
|
0.97
|
36
|
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
|
Transplantation
|
1999
|
0.96
|
37
|
Interferon-alpha-induced acute renal allograft rejection.
|
Transplantation
|
1995
|
0.95
|
38
|
Tacrolimus rescue therapy for renal allograft rejection--five-year experience.
|
Transplantation
|
1997
|
0.95
|
39
|
Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion.
|
Am J Transplant
|
2007
|
0.92
|
40
|
Toluidine blue in the corroboration of rape in the adult victim.
|
Am J Emerg Med
|
1987
|
0.91
|
41
|
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.
|
Transplant Proc
|
1998
|
0.91
|
42
|
Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients: does dissynchronous rejection really exist?
|
Transplantation
|
2000
|
0.91
|
43
|
Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.
|
Clin Transplant
|
1997
|
0.90
|
44
|
PORCN gene mutations and the protean nature of focal dermal hypoplasia.
|
Br J Dermatol
|
2009
|
0.90
|
45
|
Toluidine blue in the detection of perineal lacerations in pediatric and adolescent sexual abuse victims.
|
Pediatrics
|
1986
|
0.90
|
46
|
Methods for the detection of non-random base substitution in virus genes: models of synonymous nucleotide substitution in picornavirus genes.
|
Virus Genes
|
1998
|
0.89
|
47
|
Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation.
|
Transplant Proc
|
2005
|
0.88
|
48
|
Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report.
|
Transplant Proc
|
1991
|
0.87
|
49
|
Relationship of cytoskeletal filaments to annular gap junction expression in human adrenal cortical tumor cells in culture.
|
Exp Cell Res
|
1997
|
0.86
|
50
|
Reversal of acute cellular rejection after renal transplantation with Campath-1H.
|
Transplant Proc
|
2005
|
0.86
|
51
|
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.
|
Transplant Proc
|
1993
|
0.85
|
52
|
Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies.
|
Transpl Immunol
|
1994
|
0.85
|
53
|
The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.
|
Clin Transpl
|
1995
|
0.85
|
54
|
Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity.
|
J Am Soc Nephrol
|
1995
|
0.85
|
55
|
Centrosome proteins: a major class of autoantigens in scleroderma.
|
J Clin Immunol
|
1999
|
0.84
|
56
|
Tacrolimus nephrotoxicity after renal transplantation.
|
Transplant Proc
|
1997
|
0.83
|
57
|
Reducing the length of stay after kidney transplantation--the intensive outpatient unit.
|
Clin Transplant
|
1998
|
0.82
|
58
|
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression.
|
Transplantation
|
1996
|
0.82
|
59
|
Renal transplantation in recipients over the age of 60: the impact of donor age.
|
Transplantation
|
1999
|
0.82
|
60
|
Cancer risk with alemtuzumab following kidney transplantation.
|
Clin Transplant
|
2013
|
0.81
|
61
|
Tacrolimus for rescue of refractory renal allograft rejection.
|
Transplant Proc
|
1998
|
0.81
|
62
|
Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy.
|
Transplant Proc
|
1991
|
0.81
|
63
|
FK 506 used as rescue therapy for human liver allograft recipients.
|
Transplant Proc
|
1991
|
0.80
|
64
|
Computer-guided randomized concentration-controlled trials of tacrolimus in autoimmunity: multiple sclerosis and primary biliary cirrhosis.
|
Ther Drug Monit
|
1996
|
0.80
|
65
|
Influenza virus haemagglutinin signal sequence.
|
FEBS Lett
|
1979
|
0.80
|
66
|
Family awareness demonstrated by family practice residents: physician behavior and patient opinions.
|
J Fam Pract
|
1985
|
0.79
|
67
|
Vitamin K deficiency with hemorrhage after kidney and combined kidney-pancreas transplantation.
|
Am J Kidney Dis
|
1999
|
0.79
|
68
|
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection.
|
Transplant Proc
|
1997
|
0.79
|
69
|
Two-year experience with FK 506 in pediatric patients.
|
Transplant Proc
|
1993
|
0.78
|
70
|
Functional analysis of hamster kidney xenografts in the rat: possible functional incompatibility and adaptation of hamster kidney grafts in a xenogenic rat environment.
|
Transplant Proc
|
1996
|
0.78
|
71
|
Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up.
|
Transplant Proc
|
1999
|
0.78
|
72
|
In vitro effects of cyclosporine and FK 506 on the renal cortex.
|
Transplant Proc
|
1991
|
0.78
|
73
|
Quantitative analysis of 23-valent 'Pneumovax' by automated rate nephelometry.
|
J Biol Stand
|
1984
|
0.77
|
74
|
The effect of potassium ion depletion on postinfarction canine cardiac arrhythmias.
|
Circulation
|
1988
|
0.77
|
75
|
FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression.
|
Transplant Proc
|
1993
|
0.77
|
76
|
Kidney transplantation with bone marrow augmentation: five-year outcomes.
|
Transplant Proc
|
2001
|
0.76
|
77
|
Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome.
|
Transplant Proc
|
1995
|
0.76
|
78
|
Percutaneous transluminal renal angioplasty in nonatherosclerotic renovascular hypertension. Long-term results.
|
Hypertension
|
1985
|
0.75
|
79
|
Laboratory preparedness in EU/EEA countries for detection of novel avian influenza A(H7N9) virus, May 2013.
|
Euro Surveill
|
2014
|
0.75
|
80
|
Posttransplant hypertension in blacks versus nonblacks.
|
Transplant Proc
|
1993
|
0.75
|
81
|
Alopecia as a consequence of tacrolimus therapy.
|
Transplantation
|
1998
|
0.75
|
82
|
A tuberculosis outbreak in a renal transplant program.
|
Transplant Proc
|
1991
|
0.75
|
83
|
Outcome of kidney transplantation in African-Americans using tacrolimus.
|
Transplant Proc
|
1997
|
0.75
|
84
|
A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report.
|
J Urol
|
1998
|
0.75
|
85
|
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
|
Transplant Proc
|
2002
|
0.75
|
86
|
A comparison of the renal effects (ERPF, GFR, and FF) of FK 506 and cyclosporine in patients with liver transplantation.
|
Transplant Proc
|
1991
|
0.75
|
87
|
Acyclovir/cytomegalovirus immune globulin combination therapy for CMV prophylaxis in high-risk renal allograft recipients.
|
Transplant Proc
|
1995
|
0.75
|
88
|
Effect of recipient race on waiting time for renal transplantation at the University of Pittsburgh.
|
Transplant Proc
|
1993
|
0.75
|
89
|
Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.
|
Transplant Proc
|
1993
|
0.75
|
90
|
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.
|
Transplant Proc
|
2001
|
0.75
|
91
|
Five-year experience with tacrolimus rescue for renal allograft rejection.
|
Transplant Proc
|
1997
|
0.75
|
92
|
The galilean satellites and jupiter: voyager 2 imaging science results.
|
Science
|
1979
|
0.75
|
93
|
Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients.
|
J Transpl Coord
|
1999
|
0.75
|
94
|
Assessment of cervical carotid artery disease. A comparison between the Doppler "Echoflow" and conventional angiography.
|
Med J Aust
|
1985
|
0.75
|
95
|
ESwab challenges influenza virus propagation in cell cultures.
|
Euro Surveill
|
2014
|
0.75
|
96
|
Oral care for institutionalized geriatric patients.
|
Nurs Homes
|
1982
|
0.75
|
97
|
Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression.
|
Transplant Proc
|
2000
|
0.75
|
98
|
Inability of effluent hyaluronic acid levels to predict early graft function in clinical renal transplantation.
|
Transplantation
|
1993
|
0.75
|
99
|
Social supports and stress as predictors of illness.
|
J Fam Pract
|
1985
|
0.75
|
100
|
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
|
Transplant Proc
|
1999
|
0.75
|
101
|
Significance of polymorphonuclear leukocytes in traumatic lumbar punctures.
|
South Med J
|
1985
|
0.75
|
102
|
Future directions for the European influenza reference laboratory network in influenza surveillance.
|
Euro Surveill
|
2015
|
0.75
|
103
|
Bilateral occlusion of the subclavian veins due to chronic indwelling subclavian catheters.
|
Mil Med
|
1987
|
0.75
|
104
|
Simultaneous pancreas-kidney transplantation at the University of Pittsburgh.
|
Clin Transpl
|
1999
|
0.75
|
105
|
FK 506 interaction with danazol.
|
Lancet
|
1993
|
0.75
|
106
|
Superior vena cava syndrome due to subclavian hemodialysis catheters.
|
Mil Med
|
1990
|
0.75
|
107
|
Computer-guided concentration-controlled trials in autoimmune disorders.
|
Ther Drug Monit
|
1993
|
0.75
|
108
|
A spectroscopic investigation of losartan polymorphs.
|
Pharm Res
|
1993
|
0.75
|
109
|
[Clinical experience with FK 506].
|
Presse Med
|
1991
|
0.75
|
110
|
Interviewing style and response to family information by family practice residents.
|
Fam Med
|
1987
|
0.75
|